Showing results (521-530 of 7,003) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|October 14, 2019
Prognostic factors after treatment for iterative thymoma recurrences: A multicentric experienceMarco Chiappetta, Edoardo Zanfrini, Luca Giraldi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2019
Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancerSeong Yong Park, Go Eun Byun, Chang Young Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2019
Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancerBryan J Ager, Stacey M Wells, Joshua D Gruhl, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Treatment, no treatment and early death in Danish stage I lung cancer patientsNiels Lyhne Christensen, Susanne Dalton, Jesper Ravn, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017Mickaël Lattuca-Truc, Jean-François Timsit, Matteo Giaj Levra, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestosPatrick Maisonneuve, Cristiano Rampinelli, Raffaella Bertolotti, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancerChen Lin, Xun Shi, Shao Yang, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape ProjectKeith M Kerr, Erik Thunnissen, Urania Dafni, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2018
Characterization of TIM-3 expression and its prognostic value in patients with surgically resected lung adenocarcinomaHang Su, Huikang Xie, Chenyang Dai, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2018
Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancerKeke Nie, Zhongfa Zhang, Chunling Zhang, et al.
Pageof 701